Managing In-Use Medication Expirations
To ensure product stability, sterility and efficacy, many therapeutic products have a shortened expiration date when opened, as specified by the manufacturer. The following list(s) includes medications commonly used in community care settings where labeling indicates a shortened expiration date is required once in use. This list is not all-inclusive, consult the product labeling or check in with pharmacy for clarification on additional product(s).
Key Protocols:
- Determine the Beyond Use Date (BUD): Directives for shortened expiration date labeling is often included in the ‘How Supplied / Storage & Handling’ section of the Package Insert (PI) for the product. This information can also be found regularly on product packaging (i..e. inhalers, eye drops). The Beyond Use Date (BUD) is either the manufacturer’s printed expiration date OR the shortened post opening date—whichever comes first.
- Affix BUD Label: If the medication requires a shortened expiration date, use an auxiliary sticker to indicate ‘DATE OPENED’ AND ‘EXPIRATION DATE’ using the shortened expiration date as guidance. If an auxiliary label is not available, mark a permanent part of the packaging.
- Routine Audits: All medication should be checked for valid expiration dating during medication pass. Administering an expired medication product is considered a preventable medication error. Regularly schedule unit medication storage and cart audits to screen inventory for proper expiration date labeling and remove expired drug products.
| Respiratory | ||
|---|---|---|
| Generic Name | Brand Name | Beyond Use Date (BUD) Notes |
| Acetylcysteine | Mucomyst | Store unopened vials at room temperature; once opened, store under refrigeration and use within 96 hours. A color change may occur in opened vials (light purple) and does not affect the safety or efficacy. |
| Aclidinium | Tudorza | 45 days after opening pouch, when device locks out, or when dose indicator displays 0. |
| Aclidinium/Formoterol | Duaklir Pressair | 2 months after opening bag, when device locks out, or when dose indicator displays 0. |
| Arformoterol | Brovana solution | Prior to dispensing, store in protective foil pouch under refrigeration at 2°C to 8°C (36°F to 46°F). Protect from light and excessive heat. After dispensing, unopened foil pouches may be stored at 20°C to 25°C (68°F to 77°F) for up to 6 weeks. Only remove vial from foil pouch immediately before use. |
| Albuterol | ProAir RespiClick | 13 months after opening foil pouch or when counter reads 0. |
| Ventolin HFA | 12 months after removal from foil pouch or when counter reads 0. | |
| Albuterol/Budesonide | Airsupra | 12 months after opening foil pouch or when dose indicator displays 0. |
| Albuterol/Ipratropium | Combivent Respimat | 3 months after first actuation or when device locks out. |
| Duoneb | Store in foil and away from heat and light. Unit-dose vials should remain stored in protective foil pouch at all times. Once removed from the foil pouch, the individual vials should be used within one week. Discard if the solution is not colorless. | |
| Budesonide | Pulmicort Respules | When an envelope has been opened, the shelf life of the unused ampules is 2 weeks when protected. Return unused ampules to the aluminum foil envelope after opening, to protect them from light. Any opened ampule must be used promptly. |
| Budesonide/Formoterol | Symbicort | 3 months after removal from foil pouch or when counter reads 0. |
| Breyna | 3 months after removal from foil pouch. | |
| Fluticasone | Flovent Diskus | 50mcg strength: 6 weeks after removal from protective foil pouch or when counter reads 0. 100mcg and 250mcg strength: 2 months after removal from foil pouch or when counter reads 0. |
| Arnuity Ellipta | 6 weeks after removal from foil pouch or when counter reads 0. | |
| Fluticasone/Salmeterol | Advair Diskus | 30 days after removal from protective foil pouch or when counter reads 0. |
| AirDuo Respimat | 30 days after removal from foil pouch or when the counter reads 0. | |
| Wixela Inhub | 30 days after removal from foil pouch or when the counter reads 0. | |
| Fluticasone/Vilanterol | Breo Ellipta | 6 weeks after removal from foil tray pouch or when counter reads 0. |
| Fluticasone/Vilanterol/Umeclidinium | Trelegy Ellipta | 6 weeks after removal from foil tray or when counter reads 0. |
| Formoterol | Foradil Aerolizer | Capsules should always be stored in the blister and only removed immediately before use, discard by the manufacturer’s expiration date on product. |
| Perforomist Inhalation Solution | Prior to dispensing, store in refrigerator at 2°C to 8°C (36°F to46°F). After dispensing, store in refrigerator at 2°C to 8°C (36°F to 46°F) or room temperature at 20°C to 25°C (68°F to 77°F) for up to 3 months. Protect from light and heat. Unit-dose vials should always be stored in the foil pouch and only removed immediately before use. | |
| Glycopyrrolate/Formoterol | Bevespi Aerosphere | 3 months after removal from foil pouch or when dose indicator reads 0. |
| Glycopyrrolate/Formoterol/Budesonide | Breztri Aerosphere | 3 months (120-inhalation cannister) or 3 weeks (28-inhalation cannister) after removal from foil pouch or when counter reads 0. |
| Levalbuterol | Xopenex Solution | 2 weeks from when foil pouch is opened. Vials removed from the pouch, if not used immediately, should be protected from light and used within 1 week. |
| Mometasone | Asmanex Twisthaler | 45 days after removal from foil pouch or when the counter reads 0. |
| Olodaterol | Striverdi Respimat | 3 months after cartridge is inserted into inhaler or when device locking mechanism is engaged. |
| Salmeterol | Serevent Diskus | 6 weeks after removal from foil pouch or when counter reads 0. |
| Tiotropium | Spiriva Respimat | 3 months after first use or when device locking mechanism is engaged. |
| Spiriva Handihaler | Only remove from foil immediately before use, once removed, the capsule should be used immediately; if capsule is not used immediately it should be discarded. | |
| Tiotropium/Olodaterol | Stiolto Respimat | 3 months after cartridge is inserted into inhaler or when locking mechanism is engaged. |
| Umeclidinium | Incruse Ellipta | 6 weeks after opening the foil tray or when the counter reads 0. |
| Umeclidinium/Vilanterol | Anoro Ellipta | 6 weeks after opening the foil tray or when the counter reads 0. |
| Insulins | |||
|---|---|---|---|
| Generic Name | Brand Name | Beyond Use Date (BUD) Notes After Accessing Insulin for First Use | |
| Rapid Acting (RA) | I. glulisine | Apidra | vial – 28 days/pen – 28 days |
| I. lispro-aabc | Lyumjev | vial – 28 days/pen – 28 days | |
| I. aspart | Novolog | vial – 28 days/pen – 28 days | |
| I. lispro | Fiasp | vial – 28 days/pen – 28 days | |
| Short Acting (SA) | I. Regular | Novolin-R | vial – 42 days/pen – 28 days |
| Humulin-R | vial – 31 days | ||
| Intermed. Acting | I. NPH | Novolin-N | vial – 42 days/pen – 28 days |
| Humulin-N | vial – 31 days/pen – 14 days | ||
| Long Acting | I. glargine | Lantus | vial – 28 days/pen – 28 days |
| Toujeo | pen – 56 days | ||
| Semglee | vial – 28 days/pen – 28 days | ||
| Basaglar | pen – 28 days | ||
| I. degludec | Tresiba | vial – 56 days/pen – 56 days | |
| 70/30 RA MIX | I. aspart protamine susp / I. aspart | Novolog 70/30 | vial – 28 days/pen – 14 days |
| 70/30 SA MIX | I. NPH / I. Regular | Novolin 70/30 | vial – 42 days/pen – 28 days |
| Humulin 70/30 | vial – 31 days/pen – 10 days | ||
| 75/25 RA MIX | I. lispro protamine / I. lispro | Humalog 75/25 | vial – 28 days/pen – 10 days |
| 50/50 RA MIX | I. lispro protamine / I. lispro | Humalog 50/50 | pen – 10 days |
| U-500 Strength | I. Regular | Humulin-R U-500 | vial – 40 days/pen – 28 days |
Please see the HealthDirect – RX Guides: Insulin / GLP-1 Expiration Guide (June 2026) for further detailed information, such as pre-use and in-use.
| Miscellaneous | |||
|---|---|---|---|
| Generic Name | Brand Name | Beyond Use Date (BUD) Notes After Accessing Insulin for First Use | |
| Eye | Latanoprost | Xalatan | 6 weeks (42 days) after opening or moving to room temp. |
| Latanoprostene Bunod | Vyzulta | 8 weeks (56 days) after opening or moving to room temp. | |
| Nasal | Calcitonin Nasal Spray | Miacalcin Nasal Spray | 30 doses OR 35 days at room temp (opened or unopened). |
| Solutions | Epoetin Alfa | Epogen (Multidose) Procrit (Multidose) | Store unused portions of Epogen/Procrit in multiple- dose vials at 36°F to 46°F (2°C to 8°C). Discard 21 days after initial entry. |
| Furosemide Soln. | Lasix | Discard open bottle after 90 days. | |
| Lorazepam Soln. | Ativan Intensol | 90 days after opening [REFRIGERATED]. | |
| Subcutaneous | Liraglutide | Victoza/Saxenda | 30 days at controlled room temperature (15°C to 30°C) or in a refrigerator (2°C to 8°C). Keep the pen cap on when not in use and protect from excessive heat and sunlight. |
| Semaglutide | Ozempic | 56 days after opening at controlled room temperature (15°C to 30°C) or in a refrigerator (2°C to 8°C). Do not freeze, keep the pen cap on when not in use, and protect from excessive heat and sunlight. | |
| Wegovy | If needed, prior to cap removal, the single-use Wegovy pen can be kept from 8°C to 30°C up to 28 days. | ||
| Tests | Tuberculin Tests | Tubersol | 30 days after opening [REFRIGERATED]. |
| Bulk | Bulk PO Meds | I.e., Tylenol, Miralax, etc. | Store and discard per manufacturer instructions, unless more stringent Beyond Use Date is applied per adopted policy or local regulation. |
| Injectable MDV’s | Generally, all Injectable Multi-Dose Vials (unless individual products’ PIs state otherwise) | 28 days after opening [REFRIGERATED]. | |
| DM Supplies | Glucose Control Solutions and Test Strips | I.e., Accu-Chek, FreeStyle, etc. | Most: 90 days after opening. CHECK BRAND and that particular manufacturer’s recommendation. |
© 2026 HealthDirect Pharmacy Services MTK-1338 June 2026

